Roivant Sciences Ltd (ROIV)
Who owns Roivant Sciences Ltd (ROIV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.4% of the shares are freely tradable; institutional investors hold 75.9%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 10.84 | 77,981,253 | +18.5 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 7.21 | 51,828,325 | -11.2 | 03/31/2026 |
| BlackRock Inc | 6.15 | 44,254,260 | +7.5 | 03/31/2026 |
| Vanguard Group Inc | 5.85 | 42,059,041 | +8.4 | 12/31/2025 |
| Qvt Financial LP | 3.50 | 25,161,237 | -4.6 | 03/31/2026 |
| UBS Group AG | 3.14 | 22,619,472 | +23.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.88 | 20,680,572 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.76 | 19,838,698 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.09 | 29,430,461 | +1.2 | 04/30/2026 |
| Fidelity Growth Company Fund | 3.11 | 22,338,065 | +1.3 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Venker Eric | President & Immunovant CEO | Sell | 200,000 | 34.95 | 6,990,000 |
| 27. Jul 2026 | Venker Eric | President & Immunovant CEO | Other | 200,000 | 3.85 | 770,000 |
| 17. Jul 2026 | Momtazee James C | Director | Other | 405 | 0.00 | – |
| 17. Jul 2026 | Epperly Melissa B, | Director | Other | 543 | 0.00 | – |
| 17. Jul 2026 | Oren Ilan | Director | Other | 775 | 0.00 | – |
| 20. Apr 2026 | Eric Venker | CEO | Sell | 200,000 | 29.59 | 5,918,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.